Seaport Therapeutics reports positive phase 1 data for GlyphAgo anxiety drug

June 9, 2026 2:00 AM

Seaport Therapeutics Inc. (NASDAQ: SPTX) reported positive results from the multiple-ascending dose portion of its Phase 1 trial for GlyphAgo ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found